Rationale: Very Long-chain Acyl-CoA dehydrogenase (VLCAD) deficiency the most common inherited long-chain fatty acid disorder. The VLCAD enzyme catalyzes the first step of mitochondrial fatty acid oxidation and loss of the enzyme results in energy deficiency as well as accumulation of long chain fatty acids. Recently, a related enzyme, Long-chain Acyl-CoA dehydrogensase (LCAD), which unlike VLCAD is not highly expressed in metabolic tissues like liver, heart and skeletal muscle, was found to be expressed in the lung and surfactant and lung dysfunction were observed in LCAD deficient mice. Respiratory distress syndrome has been described in other fatty acid oxidation disorders. VLCAD is expressed in lung, and likely plays an important role i...
Background:Micewith a defect inmitochondrial fatty acid oxidation (FAO)have reduced lung function bu...
Very long chain acyl-coA dehydrogenase (VLCAD) is the rate-limiting step in mitochondrial fatty acid...
While newborn screening in lcFAO deficient patients is performed using bloodspot acylcarnitine analy...
Very-long chain acyl-CoA dehydrogenase (VLCAD) deficiency (VLCADD) is an autosomal recessive disorde...
Background: The contribution of long-chain acyl-CoA dehydrogenase (LCAD) to human fatty acid oxidati...
Nine acyl-CoA dehydrogenases (ACADs) are involved in mitochondrial fatty acid β-oxidation (FAO), an ...
<div><p>Very long-chain acyl-CoA dehydrogenase (VLCAD)-deficiency is the most common long-chain fatt...
Very long-chain acyl-coA dehydrogenase (VLCAD) is the rate-limiting step in mitochondrial fatty acid...
Very long-chain acyl-CoA dehydrogenase (VLCAD)-deficiency is the most common long-chain fatty acid o...
Fatty acids are the primary fuel source for cardiac tissue in both humans and animals. These become ...
Mitochondrial very-long-chain acyl-CoA dehydrogenase ( VLCAD) deficiency is associated with severe h...
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common inherited disorder of mitoc...
Very long-chain acyl-coA dehydrogenase (VLCAD) is responsible for catalysing the first step in the f...
Disorders of fatty acid metabolism pose a variety of problems including hypoglycemia, muscle weaknes...
SummaryVery–long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the initial rate-limiting step in mi...
Background:Micewith a defect inmitochondrial fatty acid oxidation (FAO)have reduced lung function bu...
Very long chain acyl-coA dehydrogenase (VLCAD) is the rate-limiting step in mitochondrial fatty acid...
While newborn screening in lcFAO deficient patients is performed using bloodspot acylcarnitine analy...
Very-long chain acyl-CoA dehydrogenase (VLCAD) deficiency (VLCADD) is an autosomal recessive disorde...
Background: The contribution of long-chain acyl-CoA dehydrogenase (LCAD) to human fatty acid oxidati...
Nine acyl-CoA dehydrogenases (ACADs) are involved in mitochondrial fatty acid β-oxidation (FAO), an ...
<div><p>Very long-chain acyl-CoA dehydrogenase (VLCAD)-deficiency is the most common long-chain fatt...
Very long-chain acyl-coA dehydrogenase (VLCAD) is the rate-limiting step in mitochondrial fatty acid...
Very long-chain acyl-CoA dehydrogenase (VLCAD)-deficiency is the most common long-chain fatty acid o...
Fatty acids are the primary fuel source for cardiac tissue in both humans and animals. These become ...
Mitochondrial very-long-chain acyl-CoA dehydrogenase ( VLCAD) deficiency is associated with severe h...
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common inherited disorder of mitoc...
Very long-chain acyl-coA dehydrogenase (VLCAD) is responsible for catalysing the first step in the f...
Disorders of fatty acid metabolism pose a variety of problems including hypoglycemia, muscle weaknes...
SummaryVery–long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the initial rate-limiting step in mi...
Background:Micewith a defect inmitochondrial fatty acid oxidation (FAO)have reduced lung function bu...
Very long chain acyl-coA dehydrogenase (VLCAD) is the rate-limiting step in mitochondrial fatty acid...
While newborn screening in lcFAO deficient patients is performed using bloodspot acylcarnitine analy...